64 results
Keyword Erbitux Remove keyword
-
List item
PRAC: Committee agendas, minutes and meeting highlights report archive 2012-2013
Last updated: 01/01/2015 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 2-5 December 2013
European Medicines Agency, London, UK, from 02/12/2013 to 05/12/2013, Last updated: 02/07/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 14-17 May 2018
European Medicines Agency, London, UK, from 14/05/2018 to 17/05/2018, Last updated: 14/05/2018 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 11/09/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 May 2014
European Medicines Agency, London, UK, from 05/05/2014 to 08/05/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2015
European Medicines Agency, London, UK, from 07/04/2015 to 10/04/2015, Last updated: 20/05/2015 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 2-5 September 2013
European Medicines Agency, London, UK, from 02/09/2013 to 05/09/2013, Last updated: 02/07/2012 -
List item
PRAC: meeting archive 2012-2014
Last updated: 13/05/2016 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2014
European Medicines Agency, London, UK, from 07/04/2014 to 10/04/2014, Last updated: 13/08/2013 -
List item
Press release: European Medicines Agency: Committee for Medicinal Products for Human Use 20-23 February 2006
CHMP, Last updated: 23/02/2006in the European Union: ! Erbitux (cetuximab) from Merck KGaA … CURRENT Page 2/2 ! ! Erbitux was first authorised in the … -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 May 2011
European Medicines Agency, London, UK, from 16/05/2011 to 19/05/2011, Last updated: 11/06/2010Restrictions on use of Erbitux The Committee recommended … restriction of indication for Erbitux (cetuximab) from Merck … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 June 2014
European Medicines Agency, London, UK, from 10/06/2014 to 13/06/2014, Last updated: 13/08/2013 -
List item
Download medicine data
Last updated: 02/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-27 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 24/01/2022 to 27/01/2022, Last updated: 16/03/2022 -
List item
2005 EMEA/CHMP Workshop on Biomarkers
London, 17/12/2005, Last updated: 17/12/2005 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 July 2022
PRAC, Last updated: 08/07/2022 -
List item
CHMP: meeting archive 2001-2009
Last updated: 18/11/2013 -
List item
Press release: European Agency for the Evaluation of Medicinal Products: Committee for Proprietary Medicinal Products, 23-24 March 2004
Last updated: 25/03/2004authorisation applications for: Erbitux (cetuximab), from Merck KGaA … -
List item
News: 2012 annual report on EudraVigilance published
Last updated: 26/07/2013 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2021
PRAC, Last updated: 11/06/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 November - 1 December 2022
PRAC, Last updated: 02/12/2022 -
List item
Annual reports and work programmes
Last updated: 28/06/2023 -
List item
Sampling and testing
Last updated: 28/03/2019 -
List item
EudraVigilance
Last updated: 25/03/2020 -
List item
Public data from Article 57 database
Last updated: 30/06/2023